What’s the word at RSNA 2013 – Day 3

CHICAGO—RSNA is a chance for those in the radiology community to meet, swap stories and share information about the latest developments in imaging. In that spirit, Health Imaging will be talking to people at the meeting each day and asking them each one question. We’ll share a few responses each day, so be sure to keep an eye out for them in our newsletter or check the RSNA section of our website.

Today’s question:

What has most excited or impressed you thus far at RSNA that you’ll be bringing back to your practice or organization?


[[{"fid":"18492","view_mode":"140xauto","type":"media","attributes":{"height":140,"width":140,"style":"line-height: 1.538em; width: 100px; height: 100px; float: left; margin-right: 20px;","alt":" - Cheryl Culver","class":"media-element file-140xauto"}}]]“My primary reason for coming was to go to molecular imaging symposiums. I’m very interested in learning more about how we can gauge whether our treatments for cancer are working.”

Cheryl Culver Schultz, MS, Beaumont Health System, Bloomfield Hills, Mich.

 

[[{"fid":"18493","view_mode":"140xauto","type":"media","attributes":{"height":140,"width":140,"style":"line-height: 1.538em; width: 100px; height: 100px; float: left; margin-right: 20px;","alt":" - Arnon Makori","class":"media-element file-140xauto"}}]]“The collaboration and international partnership seen here is extremely important to the field of radiology and my practice.”

Arnon Makori, MD, MHA, Clalit Health Services, Hod Hasharon, Israel

 

[[{"fid":"18494","view_mode":"140xauto","type":"media","attributes":{"height":140,"width":140,"style":"line-height: 1.538em; width: 100px; height: 100px; float: left; margin-right: 20px;","alt":" - jaydev dave","class":"media-element file-140xauto"}}]]“I will be bringing back the scientific research and a few performance improvement projects that will improve quality of patient care at my institution.” 

Jaydev Dave, PhD, DABR, Thomas Jefferson University, Philadelphia

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.